LeadNearLeadNear
Adaptive Biotechnologies logo
Verified

Adaptive Biotechnologies

Education General

Founded: 2009
Headquarters: 1551 Eastlake Avenue East, Suite 200, Seattle, Washington 98102, United States
Overview
Location
Washington, United States
Headquarter
1551 Eastlake Avenue East, Suite 200, Seattle, Washington 98102, United States
No of Employees
800
Industry
Education General
Company Type
Public Company
Founded
2009
CEO
Chad Robins
Codes
SIC Code 87,873 | NAICS Code 54,541
Annual Revenue
186.2 Million USD
Total Funding
$1B
Recent Funding Amount
$250M
No of Funding Rounds
10
Founders
Chad Robins, Harlan Robins
Social Handles

Company overview

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early det

Employees by Level

C-Level

8

VP-Level

19

Director

104

Manager

178

Non-Manager

320

Top Contacts

586

Available Jobs at Adaptive Biotechnologies

Top C-suite Members of Company

Connect with key decision-makers at Adaptive Biotechnologies. View the C-suite executives and leadership team.

NameTitleContactAction
Chad RobinsChief Executive Officer, Co-Founder & Chairmac****s@adaptivebiotech.comShow details
Julie RubinsteinPresident & Chief Operating Officerj****n@adaptivebiotech.comShow details
Kyle PiskelChief Financial Officerk****l@adaptivebiotech.comShow details
Hugh ArnoldOperations Management Chief of Staffh****d@adaptivebiotech.comShow details
Dao PhoSenior Vice President, Operationsd****o@adaptivebiotech.comShow details
Lisa WeatherholtVice President, Dx Customer Operationsl****t@adaptivebiotech.comShow details
Tobias MannVice President, Software Engineeringt****n@adaptivebiotech.comShow details
Chad RobinsChief Executive Officer, Co-Founder & Chairmac****s@adaptivebiotech.comShow details
Mark KlingerVice President, Cellular Researchm****r@adaptivebiotech.comShow details
Karina CalzadillaVice President, Investor Relationsk****a@adaptivebiotech.comShow details
Hugh ArnoldOperations Management Chief of Staffh****d@adaptivebiotech.comShow details
Sharon BenzenoChief Commercial Officer, Immune Medicines****o@adaptivebiotech.comShow details

Employees Contact

Connect with company employees using the separately sourced, masked contact dataset.

Loading employee contact information…

Email formats

Discover the professional email patterns used at Adaptive Biotechnologies.

Email formatExamplePercentage
Email formats for Adaptive Biotechnologies are not available.

Email verification tool

Find and verify professional email addresses for Adaptive Biotechnologies.

Technology stack

RSS
Miscellaneous

Adaptive Biotechnologies uses RSS to enhance their digital capabilities and improve operational efficiency.

Open Graph
Miscellaneous

Adaptive Biotechnologies uses Open Graph to enhance their digital capabilities and improve operational efficiency.

HSTS
Security

Adaptive Biotechnologies uses HSTS to enhance their digital capabilities and improve operational efficiency.

Font Awesome
Font scripts

Adaptive Biotechnologies uses Font Awesome to integrate scalable vector icons into its web applications, enhancing user interface design and ensuring visual consistency across all devices.

Twitter Emoji (Twemoji)
Font scripts

Adaptive Biotechnologies uses Twitter Emoji (Twemoji) to enhance their digital capabilities and improve operational efficiency.

Fastly
CDN

Adaptive Biotechnologies uses Fastly to accelerate content delivery, enhance security, and enable real-time control at the network edge, ensuring optimal performance and reliability for web applications.

DoubleClick Floodlight
Advertising

Adaptive Biotechnologies uses DoubleClick Floodlight to enhance their digital capabilities and improve operational efficiency.

Google Tag Manager
Tag managers

Adaptive Biotechnologies uses Google Tag Manager to efficiently deploy and manage website tracking tags, marketing pixels, and analytics scripts without direct code modifications, centralizing data collection and accelerating marketing and analytics initiatives.

Underscore.js
JavaScript libraries

Adaptive Biotechnologies uses Underscore.js to simplify common JavaScript programming tasks by providing a suite of utility functions for array, object, and function operations, leading to more concise, readable, and maintainable code.

Lodash
JavaScript libraries

Adaptive Biotechnologies uses Lodash to enhance their digital capabilities and improve operational efficiency.

jQuery UI
JavaScript libraries

Adaptive Biotechnologies uses jQuery UI to enhance web applications with a robust set of ready-to-use, customizable UI widgets and interactions, simplifying development and improving user experience.

jQuery Migrate
JavaScript libraries

Adaptive Biotechnologies uses jQuery Migrate to ensure backward compatibility and smooth upgrades to newer jQuery versions by restoring deprecated features and behaviors, preventing existing scripts from breaking and aiding in code modernization.

jQuery
JavaScript libraries

Adaptive Biotechnologies uses jQuery to simplify client-side scripting, enabling faster and more efficient manipulation of the HTML DOM, event handling, animation, and AJAX interactions across various web browsers.

New Relic
RUM

Adaptive Biotechnologies uses New Relic to enhance their digital capabilities and improve operational efficiency.

Priority Hints
Performance

Adaptive Biotechnologies uses Priority Hints to enhance their digital capabilities and improve operational efficiency.

Marionette.js
JavaScript frameworks

Adaptive Biotechnologies uses Marionette.js to enhance their digital capabilities and improve operational efficiency.

Backbone.js
JavaScript frameworks

Adaptive Biotechnologies uses Backbone.js to structure client-side web applications by providing models, views, and collections, organizing JavaScript code and simplifying the development of complex single-page interfaces.

Nginx
Web servers

Adaptive Biotechnologies uses Nginx to enhance their digital capabilities and improve operational efficiency.

Yoast SEO Premium
SEO

Adaptive Biotechnologies uses Yoast SEO Premium to enhance their digital capabilities and improve operational efficiency.

Yoast SEO
SEO

Adaptive Biotechnologies uses Yoast SEO to optimize website content for search engines by providing real-time analysis and actionable recommendations, thereby improving search engine rankings and organic traffic.

Pantheon
PaaS

Adaptive Biotechnologies uses Pantheon to enhance their digital capabilities and improve operational efficiency.

Varnish
Caching

Adaptive Biotechnologies uses Varnish to cache frequently accessed web content, significantly accelerating website delivery and reducing server load for enhanced performance and user experience.

PHP
Programming languages

Adaptive Biotechnologies uses PHP to develop dynamic, data-driven web applications and websites, leveraging its robust server-side scripting capabilities for powerful and scalable online experiences.

MySQL
Databases

Adaptive Biotechnologies uses MySQL to store, manage, and retrieve structured data efficiently and reliably, powering scalable web applications and critical business operations with robust data management capabilities.

MariaDB
Databases

Adaptive Biotechnologies uses MariaDB to enhance their digital capabilities and improve operational efficiency.

WordPress
CMS

Adaptive Biotechnologies uses WordPress to enhance their digital capabilities and improve operational efficiency.

Frequently Asked Questions

What is the address of Adaptive Biotechnologies's headquarters?

Adaptive Biotechnologies is headquartered at 1551 Eastlake Avenue East, Suite 200, Seattle, Washington 98102, United States.

How can I contact Adaptive Biotechnologies by phone?

You can reach Adaptive Biotechnologies by calling their customer support number at 2066590050.

Which stock symbol does Adaptive Biotechnologies trade under?

The stock ticker for Adaptive Biotechnologies is ADPT.

What is the official website for Adaptive Biotechnologies?

You can visit Adaptive Biotechnologies's official website at www.adaptivebiotech.com.

How much revenue does Adaptive Biotechnologies generate?

Adaptive Biotechnologies reports an annual revenue of approximately 186.2 Million USD.

What is the SIC code for Adaptive Biotechnologies?

The Standard Industrial Classification (SIC) code for Adaptive Biotechnologies is 87,873.

What is the NAICS code for Adaptive Biotechnologies?

Adaptive Biotechnologies falls under the NAICS code 54,541.

How many people work at Adaptive Biotechnologies?

Adaptive Biotechnologies has a workforce of about 800 employees.

Which technologies are used by Adaptive Biotechnologies?

Adaptive Biotechnologies utilizes technologies like RSS, Open Graph, HSTS.

Who is the Chief Executive Officer (CEO) of Adaptive Biotechnologies?

The CEO of Adaptive Biotechnologies is Chad Robins.

How can I get in touch with Adaptive Biotechnologies?

To contact Adaptive Biotechnologies, call 2066590050 or visit their website at www.adaptivebiotech.com

Is Adaptive Biotechnologies a publicly traded company?

Yes, Adaptive Biotechnologies is publicly listed and trades under the stock symbol ADPT.

How much total funding has Adaptive Biotechnologies secured so far?

To date, Adaptive Biotechnologies has raised $1B across 10 funding round(s).

Which industry is Adaptive Biotechnologies part of?

Adaptive Biotechnologies operates in the Education General, Education industry.

Who are the main competitors of Adaptive Biotechnologies?

Key competitors of Adaptive Biotechnologies include Personalis, TG Therapeutics, Alector, SomaLogic

Which companies has Adaptive Biotechnologies acquired?

Acquisitions by Adaptive Biotechnologies include Sequenta .

Who holds the CFO position at Adaptive Biotechnologies?

kel serves as the Chief Financial Officer (CFO) at Adaptive Biotechnologies.

Where can I find Adaptive Biotechnologies on social media?

You can follow Adaptive Biotechnologies on Linkedin, Twitter, Facebook to stay updated with their latest news and services.

When did Adaptive Biotechnologies complete its most recent funding round?

Adaptive Biotechnologies latest funding round closed on Sep 12, 2022 with the amount of $250 Million

Who are the investors in Adaptive Biotechnologies?

Adaptive Biotechnologies is backed by 16 investors : Senator Investment Group, Undisclosed, Viking Global Investors and Viking Global Investors.
Adaptive Biotechnologies Jobs, Company Overview & Careers